Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

Usage of Human Mesenchymal Stem Cells in Cell-based Therapy: Advantages and Disadvantages.

Kim HJ, Park JS.

Dev Reprod. 2017 Mar;21(1):1-10. doi: 10.12717/DR.2017.21.1.001. Epub 2017 Mar 31. Review.

2.

Transplantation of betatrophin-expressing adipose-derived mesenchymal stem cells induces β-cell proliferation in diabetic mice.

Sun LL, Liu TJ, Li L, Tang W, Zou JJ, Chen XF, Zheng JY, Jiang BG, Shi YQ.

Int J Mol Med. 2017 Apr;39(4):936-948. doi: 10.3892/ijmm.2017.2914. Epub 2017 Mar 10.

3.

Mesenchymal Stem Cells Support Survival and Proliferation of Primary Human Acute Myeloid Leukemia Cells through Heterogeneous Molecular Mechanisms.

Brenner AK, Nepstad I, Bruserud Ø.

Front Immunol. 2017 Feb 9;8:106. doi: 10.3389/fimmu.2017.00106. eCollection 2017.

4.

In situ single cell detection via microfluidic magnetic bead assay.

Liu F, Kc P, Zhang G, Zhe J.

PLoS One. 2017 Feb 21;12(2):e0172697. doi: 10.1371/journal.pone.0172697. eCollection 2017.

5.

Molecular Imaging of Stems Cells: In Vivo Tracking and Clinical Translation.

Rizzo S, Petrella F, Politi LS, Wang P.

Stem Cells Int. 2017;2017:1783841. doi: 10.1155/2017/1783841. Epub 2017 Jan 2. No abstract available.

6.

Perivascular cells and tissue engineering: Current applications and untapped potential.

Avolio E, Alvino VV, Ghorbel MT, Campagnolo P.

Pharmacol Ther. 2017 Mar;171:83-92. doi: 10.1016/j.pharmthera.2016.11.002. Epub 2016 Nov 24. Review.

7.

Mesenchymal stem cells with Sirt1 overexpression suppress breast tumor growth via chemokine-dependent natural killer cells recruitment.

Yu Y, Liu Y, Zong C, Yu Q, Yang X, Liang L, Ye F, Nong L, Jia Y, Lu Y, Han Z.

Sci Rep. 2016 Oct 26;6:35998. doi: 10.1038/srep35998.

8.

Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches.

Diehl R, Ferrara F, Müller C, Dreyer AY, McLeod DD, Fricke S, Boltze J.

Cell Mol Immunol. 2017 Feb;14(2):146-179. doi: 10.1038/cmi.2016.39. Epub 2016 Oct 10. Review.

9.

Mesenchymal Stem Cell Therapy for the Treatment of Vocal Fold Scarring: A Systematic Review of Preclinical Studies.

Wingstrand VL, Grønhøj Larsen C, Jensen DH, Bork K, Sebbesen L, Balle J, Fischer-Nielsen A, von Buchwald C.

PLoS One. 2016 Sep 15;11(9):e0162349. doi: 10.1371/journal.pone.0162349. eCollection 2016.

10.
11.

High Fat Diet-Induced Skeletal Muscle Wasting Is Decreased by Mesenchymal Stem Cells Administration: Implications on Oxidative Stress, Ubiquitin Proteasome Pathway Activation, and Myonuclear Apoptosis.

Abrigo J, Rivera JC, Aravena J, Cabrera D, Simon F, Ezquer F, Ezquer M, Cabello-Verrugio C.

Oxid Med Cell Longev. 2016;2016:9047821. doi: 10.1155/2016/9047821. Epub 2016 Aug 8.

12.

Computational identification of miRNAs that modulate the differentiation of mesenchymal stem cells to osteoblasts.

Seenprachawong K, Nuchnoi P, Nantasenamat C, Prachayasittikul V, Supokawej A.

PeerJ. 2016 Apr 26;4:e1976. doi: 10.7717/peerj.1976. eCollection 2016.

13.

Induced Pluripotent Stem Cell Therapies for Cervical Spinal Cord Injury.

Doulames VM, Plant GW.

Int J Mol Sci. 2016 Apr 9;17(4):530. doi: 10.3390/ijms17040530. Review.

14.

Antiangiogenic mechanisms and factors in breast cancer treatment.

Castañeda-Gill JM, Vishwanatha JK.

J Carcinog. 2016 Feb 12;15:1. doi: 10.4103/1477-3163.176223. eCollection 2016. Review.

15.

Characterization of bone marrow-derived mesenchymal stem cells from dimethyloxallyl glycine-preconditioned mice: Evaluation of the feasibility of dimethyloxallyl glycine as a mobilization agent.

Ge T, Yu Q, Liu W, Cong L, Liu L, Wang Y, Zhou L, Lin D.

Mol Med Rep. 2016 Apr;13(4):3498-506. doi: 10.3892/mmr.2016.4945. Epub 2016 Feb 29.

16.

Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: a prospective, non-randomized study.

Pan GH, Chen Z, Xu L, Zhu JH, Xiang P, Ma JJ, Peng YW, Li GH, Chen XY, Fang JL, Guo YH, Zhang L, Liu LS.

Oncotarget. 2016 Mar 15;7(11):12089-101. doi: 10.18632/oncotarget.7725.

17.

Biological characterization of metanephric mesenchymal stem cells from the Beijing duck.

Chen J, Pu Y, Sun Y, Zhang P, Li Q, Wang K, Wang W, Ma Y, Guan W.

Exp Ther Med. 2016 Feb;11(2):439-447. Epub 2015 Dec 16.

18.

Development of a Xeno-Free Feeder-Layer System from Human Umbilical Cord Mesenchymal Stem Cells for Prolonged Expansion of Human Induced Pluripotent Stem Cells in Culture.

Zou Q, Wu M, Zhong L, Fan Z, Zhang B, Chen Q, Ma F.

PLoS One. 2016 Feb 16;11(2):e0149023. doi: 10.1371/journal.pone.0149023. eCollection 2016.

19.

Comparison of Signaling Pathways Gene Expression in CD34(-) Umbilical Cord Blood and Bone Marrow Stem Cells.

Stojko R, Bojdys-Szyndlar M, Drosdzol-Cop A, Madej A, Wilk K.

Stem Cells Int. 2016;2016:5395261. doi: 10.1155/2016/5395261. Epub 2015 Dec 29.

20.

Effect of bone mesenchymal stem cells transplantation on the micro-environment of early osteonecrosis of the femoral head.

Song H, Tao L, Wang F, Wang W, Wei Y, Shen W, Zhou F.

Int J Clin Exp Pathol. 2015 Nov 1;8(11):14528-34. eCollection 2015.

Supplemental Content

Support Center